chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Primary symptom - pain at injection site. Redness in SQ tissue distal for 1 inch, no induration. Subsequent to vaccine child with nausea, later vomiting, mild headache. No signs of dehydration.
Dizziness, right low back pain, abdominal pain/ heaviness.  right pelvic pain.
5 minutes after vaccination monitoring client had blurred vision, diaphoretic X@ altered pressure in ear, and alter mental status.  Had eaten lunch- chick-fila and had no medical HX  Vitals taken twice  P48, BP 100/50, R16 O2 96% EKG sinus bradia, Near Syncopal P53, BP 88/51, R 20, O2 98%
Fever of 103 Chills Body No treatments.   Recovered in 24 hours
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 51-year-old female patient who received SHINGRIX. On 26th April 2018, the patient received the 1st dose of SHINGRIX. In April 2018, 2 days after receiving SHINGRIX, the patient experienced shingles, chills, fever and fatigue. On 7th May 2018, the patient experienced blister. In May 2018, the patient experienced injection site rash and injection site pain. The patient was treated with OTC medicines and Ice Pack (Nos). On an unknown date, the outcome of the shingles, chills, fever, fatigue, injection site rash, injection site pain and blister were unknown. It was unknown if the reporter considered the shingles, chills, fever, fatigue, injection site rash, injection site pain and blister to be related to SHINGRIX. Additional details were provided as follows: The patient reported that she had a healthy immune system as noted in her recent lab work and overall health and lifestyle. The patient received SHINGRIX vaccine on an unknown deltoid during her annual physical. The patient, 2 days later experienced chills, fever and fatigue. About 10 day after that the patient developed a painful rash on my upper arm where the vaccine was given. The patient called her doctor who assured her that it was just a coincidence and that she should treat it with OTC (over the counter) medicines and ice. The patient did that and by the past Monday 11 days post vaccination, the pain was bad and it began to blister. The patient went to the doctor a day before date of reporting and was diagnosed with Shingles. The patient was doubtful that this was a coincidence. The patient thought it was important that this information was to be shared as the vaccine was so newly released.
I had suffered from fatigue. Feeling tired all throughout the day, my motivation was low. This carried on for several weeks. I did not see my doctor but I did talk to my doctor. He said to get back to him in several weeks if things worsened, but it did not.
On 09/08/2001, swelling and hardness, red and hot to touch at site of injection about the size of an egg. Itched, temp 98.7.  To ER given antibiotic, lasted about 3 days. Took Keflex 500mg every 6 hours for 10 days.
Anaphylaxis including  full body urticaria and pruritis, coughing, and bronchial constriction. Immediately took Benadryl and albuterol which helped improve symptoms over about an hour.   I had COVID infection about six months ago and recovered without incident from that.
The symptoms started a few hours after the shot, feeling tired and fatigued.  About 16 hrs after the injection, 4/12/2021 at approximately 3:30 AM I woke up feverish, chills, nauseous and with a bad headache.  When I got out of bed I felt dizzy.  I was so dizzy I must have fainted on our bathroom floor as I was returning to my bed.  My husband had to carry me to bed.  I had these symptoms for approximately 24hrs.  On 4/13/2021 I still felt fatigues and dizzy.  Today, 4/14/2021 I  am still fatigued and dizzy.
redness, inflammation, itching, warm to touch surrounding injection site size grew to approximately 25cm by 14cm over a 2 day period inflammation, warmth, and redness subsided in 6 days occasional itching, numbness, and appears to be slight discolorization/bruising remaining
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patient was vaccinated with PNEUMOVAX 23. The pharmacist reported that the patient was receiving a dose every three years since an unspecified date. No adverse effect was reported. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified patient of unknown age and gender. No concurrent condition and medical history were provided. On 05-JUN-2015, the patient was inadvertently administered with a dose of (Oka/Merck) VARIVAX (dose, anatomical location, lot number and expiration date not reported) subcutaneous for prophylaxis instead a dose of ZOSTAVAX. No adverse effects were reported. Laboratory diagnostics studies were not informed. At the time of the report the outcome of wrong drug administered was unknown. Additional information has been requested.
3 patients were given full dose as a booster; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (3 patients were given full dose as a booster) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 02-Nov-2021, the patient experienced ACCIDENTAL OVERDOSE (3 patients were given full dose as a booster). On 02-Nov-2021, ACCIDENTAL OVERDOSE (3 patients were given full dose as a booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided.
No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 32-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 13-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.).     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No concomitant medication were reported.             No treatment information was provided by the reporter.
HAD THE SHOTS GOT SCHINGLES ANAWAY/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 17-AUG-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received shots of Shingles vaccine and experienced shingles. The patient had shingles at the time of reporting. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible, as no contact, details were available.
Information has been received from a registered nurse concerning a 26 year old male with a history of a splenectomy following a motor vehicle accident in 1995 who on 02/13/2002 was vaccinated with pneumococcal vaccine 23 polyvalent in his right deltoid. The nurse reported that the pt was well at the time of the vaccination. On 02/14/2002 the pt called into the office and spoke to the on-call physician complaining that his right arm was red and swollen. The pt was instructed to go to the ER. The pt did not received treatment at ER and was not admitted to the hospital but was seen in his physician's office on 02/15/2002. The nurse reported that on the 02/15/2002 office visit the pt's arm "looked bad." The nurse reported that the pt was missing work because he was a right armed painter and could not work. The pt was diagnosed with cellulitis and treated with a 10 day course of Keflex. On 02/18/2002 the pt was seen again in his physician's office and the redness had gone away, however the pt was still complaining of pain and weakness. The pt was prescribed Keflex for 4 more days. On 02/22/2002 the pt was seen again for another problem and the cellulitis had resolved. Upon internal review, the cellulitis was considered to be an other medical event. Additional info has been requested.
Truly no adverse event - patient was 17 years old at time of vaccination and received Moderna product, which is indicated for ages 18 and older.  The patient and her prescriber were notified immediately and age was documented in pharmacy system.  Prescriber ok with incident as patient will be 18 years old by time second dose is due.
At 11:00 pm on 1/14/21, I awakened with chills/rigors. My temperature at that time was 103 F, taken tympanic. I took Motrin and the fever broke at 2:00 am on 1/15/21. I had an accompanying headache that lingered into the next day. I experienced muscle aches in my shoulders as well as fatigue through 1/18/21. Pain of my right upper extremity (injected arm) lasted from 1/15/21-1/18/21.
Fever of 100-101 degrees F for 60 hours, treated with acetaminophen. During this same period I experienced chills and excessive sweating. I also experienced shortness of breath, pain while yawning or coughing, and an inability to take full breaths.
Initial report received from a nurse on 12 Jan 2010: This patient who was under 4 years of age received Novartis H1N1 (batch number 102149P1) 0.25 ml intramuscularly on 11 Jan 2010. Outcome was not provided at the time of this report.
She got her vaccine, she did not have a reaction for several days until she noticed and felt like a lump under her skin where the injection was.  Then yesterday she had a big red blotch at the injection site.  Today the reaction is gone, as well as the bump underneath it.  She did not take anything for it, and did not contact her doctor.
Developed excruciating pain in back, unable to take deep breaths, severe headache, and legs weak. Instructed to report to ER or Urgent care.  She went to an ER, but did not stay due to long wait.  Symptoms subsided on their own.
Body ache, fever, chills, lasting three days and nights, unable to be out of bed or drive to doctor. Injection site sore, red, itchy and swollen for nine inches around site, and this lasted seven days.
Itching, Tingling to scalp, trapezius area of the back and arms. Experienced this 1 week after the vaccine. Patient took Allegra and symptoms resolved after 1 hour.  Patient continues to have no symptoms 24 hours after taking the Allegra.
This spontaneous report was received from a physician, via a company representative, concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 13-JAN-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2018, 0.5 ml (route and anatomical location of administration were not reported). On unspecified dates, the PNEUMOVAX 23 had five temperature excursions of 0 Celsius Degrees (32 Fahrenheit) for 168 hours, 0.55 Celsius Degrees (33 Fahrenheit) for 128 hours, -1.11 Celsius Degrees (30 Fahrenheit) for 264 hours, -1.66 Celsius Degrees (29 Fahrenheit) for 256 hours, and -0.55 Celsius Degrees (31 Fahrenheit) for 448 hours respectively. The vaccine status was reported as "in excursion" and the type of excursion and storage criteria were reported as "refrigerator (R)".  No adverse effects were reported nor Product Quality Complaint (PQC) was involved. This is one of several cases received from the same reporter. Additional information has been requested.
After vaccine administration, patient went to sit down for 15 min observation. After about 2 minutes patient passed out (fell asleep) on the chair and her friend called for help. Pharmacy staff called 911 and during the call in about 1 minute patient was awake and no longer in a fainting spell. EMS asked for patient to wait until they arrived. Her breathing was okay but patient complained that she felt sick--she was dizzy, lightheadedness, nausea and hot(face), blurry vision, and got extremely pale. Her temperature was 97.2. EMS arrived at around 1:08pm and stated will take her to the nearest hospital.
PREVNAR 13 and pneumococcal PPSV23 both vaccinated on 12-MAY-2016; This spontaneous report has been received from a physician, via a Plaintiff IR/MR from a case in litigation for zoster vaccine live (ZOSTAVAX) (MARRS # 2104USA001323), concerning a 74-year-old female patient. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided.  On 12-MAY-2016, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose, site, lot# and expiration date were unknown; route was intramuscular) and pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) (syringe, lot# 100005045157, left upper arm, route was intramuscular; dose and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration).   This is one of two cases regarding the same patient.; Sender's Comments:  US-009507513-2104USA001323:
Within 6 hours started having side-affects.   Headache (severe) Neck stiffness Dizziness Lethargy Body aches and pains Upset stomach Nausea
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 15-SEP-2015 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 03-DEC-2015, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Feeling worse; Shortness of breath; I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth; Dizziness; Tiredness; Not feeling good; Body sore; Couldnt move without feeling pain; Fever; Junctions all sore; Headaches; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), DIZZINESS (Dizziness) and FEELING ABNORMAL (Not feeling good) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00AC21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 21-Apr-2021, the patient experienced PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), FEELING ABNORMAL (Not feeling good), PYREXIA (Fever), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches). On 26-Apr-2021, the patient experienced DIZZINESS (Dizziness), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth) and FATIGUE (Tiredness). On 28-Apr-2021, the patient experienced MALAISE (Feeling worse). On 24-Apr-2021, PAIN (Body sore), MOVEMENT DISORDER (Couldnt move without feeling pain), ARTHRALGIA (Junctions all sore) and HEADACHE (Headaches) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness), FEELING ABNORMAL (Not feeling good), MALAISE (Feeling worse), DYSPNOEA (Shortness of breath), VISUAL IMPAIRMENT (I am also having problems with sense of depth, it is affecting my driving skills, I can't see in depth), PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Spider web like sensation on her face; Irritation; Short temper; Headache; This case was reported by a consumer via call center representative and described the occurrence of crawling sensation of skin in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included TETANUS TOXOID (TETANUS VACCINE) for prophylaxis.   On 26th August 2019, the patient received the 1st dose of Shingrix and TETANUS VACCINE. On an unknown date, less than a week after receiving Shingrix and an unknown time after receiving TETANUS VACCINE, the patient experienced crawling sensation of skin, irritability, short tempered and headache. On an unknown date, the outcome of the crawling sensation of skin, irritability, short tempered and headache were recovering/resolving.   It was unknown if the reporter considered the crawling sensation of skin, irritability, short tempered and headache to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine and on the same day she also received tetanus vaccine on her other arm. Within a week after she experienced a spider web like sensation on her face. She also experienced irritation, short temper and headaches.  All the side effects were still present. The reporter did not consent to follow up. No further details were provided. It was unknown if the reporter considered the crawling sensation of skin, irritation skin, short tempered and headache to be related to tetanus vaccine as well.
receiving her Covid-19 vaccine and is unfortunately having a flare from that; This is a spontaneous report from a contactable other health professional. A 21-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiration date was not reported), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and medications were not reported. Previously, the patient took XELJANZ XR (tab 11mg) and had no adverse events; and took HUMIRA and had side effects that had gone away. Reportedly, the reporter spoke with patient's mother, and it was reported that the patient reported no adverse events from XELJANZ, and she reported that her HUMIRA side effects had gone away. The patient had received her Covid-19 vaccine and was unfortunately having a flare from that on an unspecified date. The outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Rash on face / Rash is dry and is on forehead and some below the eyes; This case was reported by a pharmacist via call center representative and described the occurrence of red rash in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number LD3NH, expiry date 11th December 2021) for prophylaxis.   On 8th October 2019, the patient received the 1st dose of Shingrix (intramuscular). In October 2019, less than a week after receiving Shingrix, the patient experienced red rash. On an unknown date, the outcome of the red rash was unknown.   It was unknown if the reporter considered the red rash to be related to Shingrix.  Additional details were provided as follows: The reporter stated that the patient received first dose of Shingrix and experienced rash on his face. The reporter stated that the rash was red and dry and is on forehead and some below the eyes.
Pregnant due 8/23/21 2 hours after shot my arm began to hurt at the injection site. Went to sleep. Was awoken at 4am with severe muscle/joint/bone pain, chills, headache, neck soreness, stomach ache, nausea, fatigue. Pain is so severe (bodily/muscle pain) that I have been in bed all day long but have been unable to sleep. Also have a bit of a cough and chest feels congested . Have not seen a doctor because my symptoms are all on the list of side effects for the vaccine and I feel too weak, sore and tired to get out of bed.
On June 24,2019. Husband and I was gave the shingles shot, My husband went first, and then I went. Three weeks later I develop a rash on my left breast . I called my primary doctor, he treated me for a yest infection. Four week later the symptoms was not gone. So my primary doctor refer me to a dermatology, the dermatology took a swap culture, and a biopsy from my left breast. In a week the reult came back I have psoriasis, which I have on my belly line, my hair, and feet, genital area. two week later the swap culture came back I hae e-coli and staph infection. it only effect me and not my husband,
Hives all over middle torso, front/ back and upper neck the next day when I woke up in the morning.
Pt in the clinic with caregiver for 1st Pfizer vaccine at 955am. Pt is sitting in mobile scooter and NP was called by staff. Upon arrival, pt reported not feeling well and can not breath well and looks pale. Pt's caregiver reported that pt has history of MS and has similar reaction with blood-draw and pt does not have history of allergy to any medications. Pt's O2 Sat was 86% room air and pt was placed on O2 4L via nasal cannula and O2 sat: 100% room air. BP; 60/32, HR: 44, R: 18. 911 was called and patient transported to outside hospital at 10:20 am. Caregiver took patient's belonging.  10:10 am  BP: 83/44   HR: 54,  R: 18, O2 sat 100% 4L NC 10:13 am  BP: 67/42  HR: 56,   R: 18, O2 Sat: 100% 4L NC 10:16 am  BP: 71/46  HR: 55    R: 20  O2 sat: 100% 4L NC"
Pt developed shingles approximately 3 weeks after receiving ZOSTAVAX as confirmed  by his doctor on 10/31/14; was prescribed ZOVIRAX to treat signs and symptoms of scud virus.